Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 577.00
-21.50 (-3.59%)
Jul 22, 2026, 3:29 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 11.99 billion as of July 22, 2026. Its market cap has increased by 7.05% in one year.
Market Cap
11.99B
Enterprise Value
9.62B
Revenue
6.71B
Ranking
n/a
PE Ratio
13.64
Stock Price
577.00
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 11.99B, an increase of 8,533.11%. That is a compound annual growth rate of 22.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 11.99B | 23.90% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 47.30B |
| Solara Active Pharma Sciences | 27.50B |
| Beta Drugs | 24.62B |
| Indoco Remedies | 22.57B |
| Ind-Swift Laboratories | 20.29B |
| Sakar Healthcare | 20.00B |
| Windlas Biotech | 17.99B |
| Jagsonpal Pharmaceuticals | 14.97B |